ArticleBMJ open2025
Efficacy of a teaching kitchen program for patients with type 2 diabetes in Japan: protocol for an open-label randomised controlled trial (TKD-J trial).
Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThis open-label randomised controlled trial (Teaching Kitchen for Diabetes in Japan [TKD-J] trial) evaluates the effectiveness of a modified Teaching Kitchen program for Japanese patients with type 2 diabetes. Based on the US Teaching Kitchen Multisite Trial, this program integrates hands-on culinary instruction with evidence-based lectures on nutrition, physical activity, sleep and mindfulness, combined with a personalised approach. This is the first prospective study to assess its impact on glycaemic control and clinical, behavioural, quality-of-life outcomes among Japanese patients with type 2 diabetes. METHODS AND ANALYSIS: Two hundred adults aged 20-79 years with type 2 diabetes (HbA1c 6.5-8.9%) and either body mass index ≥23 kg/m² or abdominal obesity (waist ≥85 cm for men or ≥90 cm for women) will be recruited from Osaka University Hospital and 16 affiliated medical institutions in Japan. Participants will be randomly assigned in a 1:1 ratio to either an initial-start or a delayed intervention group (starting after a 4-month delay). The 12-month intervention includes a 4-month main program (weekly) and 8-month maintenance program (monthly), followed by a 4-month post-intervention follow-up. Data will be collected at baseline, and at months 0, 4, 8, 12 and 16. In the initial start group, the baseline and month 0 assessments coincide. In the delayed intervention group, month 0 occurs 4 months after baseline, following a control period. The primary outcome is the change in HbA1c levels during the first 4-month period, which corresponds to the randomised controlled trial phase. Secondary outcomes are changes in fasting plasma glucose, glycaemic variability assessed by blinded continuous glucose monitoring, diabetes treatment, anthropometric and metabolic measures, dietary behaviour, physical activity, sleep, quality of life, mindfulness, cooking skills and self-efficacy. In addition, program satisfaction and records collected through web application will also be assessed. Between-group and within-group changes over time will be analysed using mixed-effects linear regression models. ETHICS AND DISSEMINATION: The study has been approved by the Ethics Committee of Osaka University Hospital (approval number: 23179 [T2]). Written informed consent will be obtained from all participants. Findings will be disseminated through peer-reviewed journals, conference presentations and community outreach. TRIAL REGISTRATION NUMBER: UMIN-CTR (UMIN000052514).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.